Jiangsu GDK Biotechnology Co Ltd
医疗健康 · 生物科技
Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
MARKET 市值 1.92B CNY 52W ¥13.33 – ¥31.2
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY -74.1%
▼ ROE -15.7% 营业利润率 -2533.1% 净利润率 -166.1%